Related references
Note: Only part of the references are listed.Increased plasma DPP4 activity predicts new-onset hypertension in Chinese over a 4-year period: possible associations with inflammation and oxidative stress
T. Zheng et al.
JOURNAL OF HUMAN HYPERTENSION (2015)
Increased plasma dipeptidyl peptidase 4 activities predict new-onset microalbuminuria in association with its proinflammatory effects in Chinese without diabetes: a four-year prospective study
Tianpeng Zheng et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2015)
Elevated Circulating Pigment Epithelium-Derived Factor Predicts the Progression of Diabetic Nephropathy in Patients With Type 2 Diabetes
Elaine Hui et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Increased Plasma DPP4 Activity Is Predictive of Prediabetes and Type 2 Diabetes Onset in Chinese Over a Four-Year Period: Result From the China National Diabetes and Metabolic Disorders Study
Tianpeng Zheng et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
The protective roles of GLP-1R signaling in diabetic nephropathy: possible mechanism and therapeutic potential
Hiroki Fujita et al.
KIDNEY INTERNATIONAL (2014)
Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2012 Clinical Practice Guideline
Paul E. Stevens et al.
ANNALS OF INTERNAL MEDICINE (2013)
Advanced glycation end products evoke endothelial cell damage by stimulating soluble dipeptidyl peptidase-4 production and its interaction with mannose 6-phosphate/insulin-like growth factor II receptor
Yuji Ishibashi et al.
CARDIOVASCULAR DIABETOLOGY (2013)
CD26/clipeptidyl peptidase IV: A comparative study of healthy persons and kidney transplant recipients before and early after transplantation
Simone Leicht et al.
CLINICAL BIOCHEMISTRY (2013)
Adipose Dipeptidyl Peptidase-4 and Obesity Correlation with insulin resistance and depot-specific release from adipose tissue in vivo and in vitro
Henrike Sell et al.
DIABETES CARE (2013)
MECHANISMS OF DIABETIC COMPLICATIONS
Josephine M. Forbes et al.
PHYSIOLOGICAL REVIEWS (2013)
Renal Effects of DPP-4 Inhibitors: A Focus on Microalbuminuria
Martin Haluzik et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2013)
Plasma dipeptidyl peptidase 4 activity correlates with body mass index and the plasma adiponectin concentration in healthy young people
Yasushi Kirino et al.
ENDOCRINE JOURNAL (2012)
Dipeptidyl Peptidase 4 Is a Novel Adipokine Potentially Linking Obesity to the Metabolic Syndrome
Daniela Lamers et al.
DIABETES (2011)
Insulin Signaling to the Glomerular Podocyte Is Critical for Normal Kidney Function
Gavin I. Welsh et al.
CELL METABOLISM (2010)
Development and Progression of Renal Insufficiency With and Without Albuminuria in Adults With Type 1 Diabetes in the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications Study
Mark E. Molitch et al.
DIABETES CARE (2010)
Circulating levels of insulin-like growth factor-II/mannose-6-phosphate receptor in obesity and type 2 diabetes
Nilani Jeyaratnaganthan et al.
GROWTH HORMONE & IGF RESEARCH (2010)
Prevalence of Diabetes among Men and Women in China
Wenying Yang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Dipeptidyl Peptidase-4 (CD26): Knowing the Function before Inhibiting the Enzyme
E. Matteucci et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Improved GFR estimation by combined creatinine and cystatin C measurements
Y-C Ma et al.
KIDNEY INTERNATIONAL (2007)
Plasma dipeptidyl peptidase-IV activity in patients with type-2 diabetes mellitus correlates positively with HbAlc levels, but is not acutely affected by food intake
Jakob Ryskjaer et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2006)
Hyperglycaemia increases dipeptidyl peptidase IV activity in diabetes mellitus
L Pala et al.
DIABETOLOGIA (2005)
Soluble CD26/dipeptidyl peptidase IV enhances transendothelial migration via its interaction with mannose 6-phosphate/insulin-like growth factor II receptor
H Ikushima et al.
CELLULAR IMMUNOLOGY (2002)
Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals
HC Gerstein et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
T Nishikawa et al.
NATURE (2000)